Continuation of Oral ONC201 in Treating Patients With Advanced Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02324621
Recruitment Status : Recruiting
First Posted : December 24, 2014
Last Update Posted : August 9, 2018
National Cancer Institute (NCI)
Rutgers Cancer Institute of New Jersey
Oncoceutics, Inc.
Information provided by (Responsible Party):
Rutgers, The State University of New Jersey

No Study Results Posted on for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : March 2019
  Estimated Study Completion Date : March 2019